FR2882255B1 - Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci - Google Patents

Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci

Info

Publication number
FR2882255B1
FR2882255B1 FR0501907A FR0501907A FR2882255B1 FR 2882255 B1 FR2882255 B1 FR 2882255B1 FR 0501907 A FR0501907 A FR 0501907A FR 0501907 A FR0501907 A FR 0501907A FR 2882255 B1 FR2882255 B1 FR 2882255B1
Authority
FR
France
Prior art keywords
active ingredient
plant
precursor
solution containing
based solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0501907A
Other languages
English (en)
Other versions
FR2882255A1 (fr
Inventor
Michel Iderne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apis Spheromont
Original Assignee
Apis Spheromont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apis Spheromont filed Critical Apis Spheromont
Priority to FR0501907A priority Critical patent/FR2882255B1/fr
Priority to RU2007134858/15A priority patent/RU2007134858A/ru
Priority to EP06709369A priority patent/EP1853226A2/fr
Priority to US11/816,945 priority patent/US20090123552A1/en
Priority to CA002598226A priority patent/CA2598226A1/fr
Priority to PCT/FR2006/000409 priority patent/WO2006090066A2/fr
Publication of FR2882255A1 publication Critical patent/FR2882255A1/fr
Application granted granted Critical
Publication of FR2882255B1 publication Critical patent/FR2882255B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
FR0501907A 2005-02-24 2005-02-24 Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci Expired - Fee Related FR2882255B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0501907A FR2882255B1 (fr) 2005-02-24 2005-02-24 Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci
RU2007134858/15A RU2007134858A (ru) 2005-02-24 2006-02-23 Сфероиды, приготовленные из изолированной, активной главной компоненты растительного происхождения и раствора растительного происхождения, содержащего главную компоненту или ее прототип
EP06709369A EP1853226A2 (fr) 2005-02-24 2006-02-23 Spheroides prepares a partir d un principe actif isole d origine vegetale et d une solution d origine vegetale contenant le principe actif ou un precurseur de celui-ci
US11/816,945 US20090123552A1 (en) 2005-02-24 2006-02-23 Spheroids prepared from an isolated active principle of vegetable origin and a solution of vegetable origin containing the active principle or a precursor thereof
CA002598226A CA2598226A1 (fr) 2005-02-24 2006-02-23 Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci
PCT/FR2006/000409 WO2006090066A2 (fr) 2005-02-24 2006-02-23 Spheroides prepares a partir d’un principe actif isole d’origine vegetale et d’une solution d’origine vegetale contenant le principe actif ou un precurseur de celui-ci

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501907A FR2882255B1 (fr) 2005-02-24 2005-02-24 Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci

Publications (2)

Publication Number Publication Date
FR2882255A1 FR2882255A1 (fr) 2006-08-25
FR2882255B1 true FR2882255B1 (fr) 2008-05-16

Family

ID=35058949

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0501907A Expired - Fee Related FR2882255B1 (fr) 2005-02-24 2005-02-24 Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci

Country Status (6)

Country Link
US (1) US20090123552A1 (fr)
EP (1) EP1853226A2 (fr)
CA (1) CA2598226A1 (fr)
FR (1) FR2882255B1 (fr)
RU (1) RU2007134858A (fr)
WO (1) WO2006090066A2 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2721512A1 (fr) * 1994-06-28 1995-12-29 Maurice Jacob Formulation et procédé de préparation de sphéroïdes à base de solutions d'origine végétale.
AU1930897A (en) * 1997-03-03 1998-09-22 Laboratoires Remilea Plant extract compositions, method of preparation, and pharmaceutical comp ositions containing them
IN188174B (fr) * 1997-03-17 2002-08-31 Council Scient Ind Res
FR2794346B1 (fr) * 1999-06-02 2004-08-06 Ile D Inventeurs Apis Spheromo Formulation et procede de production de spheroides a partir d'une boisson fermentee ou d'un jus fermente par exemple du vin
FR2827771B1 (fr) * 2001-07-25 2003-10-24 Apis Spheromont Formulation et procede de preparation de spheroides pouvant etre fortement titres et a dispersion rapide

Also Published As

Publication number Publication date
EP1853226A2 (fr) 2007-11-14
CA2598226A1 (fr) 2006-08-31
WO2006090066A3 (fr) 2007-01-11
FR2882255A1 (fr) 2006-08-25
US20090123552A1 (en) 2009-05-14
WO2006090066A2 (fr) 2006-08-31
RU2007134858A (ru) 2009-03-27

Similar Documents

Publication Publication Date Title
GB2414669B (en) Extracts from plants and fish which induce the conversion of inactive TGFb-latent into its active form
EP1780202A4 (fr) Derive de quinoline et insecticide contenant cellui-ci comme constituant actif
PL375357A1 (pl) Ulepszona ekstrakcja składników farmaceutycznie aktywnych z materiałów roślinnych
ATE469163T1 (de) Phosphonat prodrogen von einem analog des 2'- fluoro-2',3'-didehydro-2',3'-dideoxyadenosins als anti-hiv mittel
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
EP1972251A4 (fr) Contenant de type capsule et procédé d'administration l'utilisant
GB2422335B8 (en) Chip for detection or analysis of biologically active substance
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
EP1717246A4 (fr) Antagonistes du tnf, et inhibiteurs du tnf les contenant en tant qu'ingredient actif
EP1909689A4 (fr) Implants contenant un medicament et leur procede d'utilisation
MA28862B1 (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
EP1770085A4 (fr) Dérivé de diamine, procédé servant à produire celui-ci et fongicide contenant le dérivé comme ingrédient actif
EP1645277A4 (fr) Preparation medicinale lyophilisee stable contenant de la tetrodotoxine
MA26346A1 (fr) Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.
FR2839451B1 (fr) Compose comprenant un polymere, un espaceur et un principe actif, composition contenant ce compose et utilisations
EP2053038A4 (fr) Dérivé d'aminoalcool et immunodépresseur le contenant en tant que principe actif
FR2848851B1 (fr) Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
BR0110069A (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
FR2882255B1 (fr) Spheroides prepares a partir d'un principe actif isole d'origine vegetale et d'une solution d'origine vegetale contenant le principe actif ou un precurseur de celui-ci
FR2876028B1 (fr) Encapsulation d'extraits vegetaux
ITRM20030596A1 (it) Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
TN2010000058A1 (fr) Composition therapeutique aromatisee a base d'argile

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20141031